These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27376763)

  • 61. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy.
    Roscigno M; Scattoni V; Freschi M; Raber M; Angiolilli D; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Feroldi L; Deiana G; Chinaglia D; Montorsi F; Da Pozzo LF
    Arch Ital Urol Androl; 2010 Dec; 82(4):242-7. PubMed ID: 21341572
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The place of prostate rebiopsy in the diagnosis of prostate cancer.
    Vida OÁ; Pricop C; Loghin A; Chiuţu LC; Mártha O
    Rom J Morphol Embryol; 2014; 55(3 Suppl):1161-6. PubMed ID: 25607400
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme.
    Scattoni V; Raber M; Capitanio U; Abdollah F; Roscigno M; Angiolilli D; Maccagnano C; Gallina A; Saccà A; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2011 Oct; 60(4):834-41. PubMed ID: 21820797
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results.
    Lee SH; Chung MS; Kim JH; Oh YT; Rha KH; Chung BH
    J Endourol; 2012 Jul; 26(7):787-91. PubMed ID: 22122555
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.
    De Nunzio C; Lombardo R; Albisinni S; Gacci M; Tubaro A
    Int Braz J Urol; 2013; 39(6):793-9. PubMed ID: 24456771
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance.
    Porcaro AB; Cavicchioli F; Mattevi D; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Tamanini I; Cacciamani G; Cerruto MA; Brunelli M; Novella G; Siracusano S; Artibani W
    Urol Int; 2017; 98(1):32-39. PubMed ID: 27798942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
    Pepe P; Pennisi M; Fraggetta F
    Int Braz J Urol; 2015; 41(5):844-8. PubMed ID: 26689509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.
    Al-Azab R; Toi A; Lockwood G; Kulkarni GS; Fleshner N
    Urology; 2007 Jan; 69(1):103-7. PubMed ID: 17270628
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy.
    Yoon BI; Shin TS; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
    Urol J; 2012; 9(2):491-7. PubMed ID: 22641493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
    Li YH; Elshafei A; Li J; Hatem A; Zippe CD; Fareed K; Jones JS
    Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.
    Yilmaz H; Ustuner M; Ciftci S; Yavuz U; Ozkan TA; Dillioglugil O
    Int Braz J Urol; 2014; 40(5):613-9. PubMed ID: 25498272
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.
    Porcaro AB; Mattevi D; Novella G; De Luyk N; Corsi P; Bizzotto L; De Marchi D; Sebben M; Tafuri A; Inverardi D; Processali T; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Curr Urol; 2018 Feb; 11(2):85-91. PubMed ID: 29593467
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.
    Porcaro AB; Novella G; Mattevi D; Bizzotto L; Cacciamani G; Luyk ND; Tamanini I; Cerruto MA; Brunelli M; Artibani W
    Curr Urol; 2016 May; 9(2):82-92. PubMed ID: 27390581
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association between prostate size and the incidence of prostate cancer: a meta-analysis and review for urologists and clinicians.
    Moolupuri A; Camacho J; de Riese WT
    Int Urol Nephrol; 2021 Oct; 53(10):1955-1961. PubMed ID: 34024008
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Words of wisdom. Re: Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Damiano R; Cicione A; Cantiello F
    Eur Urol; 2015 May; 67(5):972-3. PubMed ID: 25845958
    [No Abstract]   [Full Text] [Related]  

  • 80. Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years.
    Yamashiro JR; de Riese WTW
    Res Rep Urol; 2021; 13():749-757. PubMed ID: 34676178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.